Nucleic acid-encapsulating polymer micelle complex and method for producing same

US10046065B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10046065-B2
Application numberUS-201414909162-A
CountryUS
Kind codeB2
Filing dateAug 5, 2014
Priority dateAug 6, 2013
Publication dateAug 14, 2018
Grant dateAug 14, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A nucleic acid-encapsulating polymer micelle complex is formed of a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block; and two single-stranded DNA molecules having mutually complementary base sequences of 1000 or more bases in length, double-stranded DNA of 1000 or more base pairs in length in which at least a part of a double helix structure is dissociated and forms a single-stranded structure, or one single-stranded DNA molecule of 1000 or more bases in length.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a nucleic acid-encapsulating polymer micelle complex which accommodates DNA, the method comprising: a process of mixing a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block with double-stranded DNA of 1000 or more base pairs in a state in which at least a part of the double-stranded DNA is denatured in an aqueous medium; wherein the double-stranded DNA has been denatured at 80° C. or higher prior to the process of mixing with the block copolymer, and the complex is spherical and has diameters having a ratio of a longest diameter to another diameter of 1:1. 2. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the double-stranded DNA is 2000 or more base pairs in length. 3. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the double-stranded DNA is linear. 4. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the average particle diameter thereof in an aqueous medium measured according to a dynamic light scattering method is 100 nm or less. 5. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the DNA and the cationic polymer chain block bonded to the DNA due to an electrostatic interaction form a core portion, and the uncharged hydrophilic polymer chain block forms a shell portion. 6. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 5 , wherein the average particle diameter of the core portion is 50 nm or less. 7. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein at least a part of the block copolymer is mutually cross-linked. 8. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein a hydrophobic group is covalently bonded to a main chain or a side chain of the cationic polymer chain block. 9. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the cationic polymer chain block has an ethylamine structure or a propylamine structure in the side chain thereof.

Assignees

Inventors

Classifications

  • Purification or manufacturing processes for gene therapy compositions · CPC title

  • Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy · CPC title

  • Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links · CPC title

  • A61K47/34Primary

    Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title

  • Double-stranded nucleic acids or oligonucleotides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10046065B2 cover?
A nucleic acid-encapsulating polymer micelle complex is formed of a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block; and two single-stranded DNA molecules having mutually complementary base sequences of 1000 or more bases in length, double-stranded DNA of 1000 or more base pairs in length in which at least a part of a double helix struc…
Who is the assignee on this patent?
Japan Science & Tech Agency
What technology area does this patent fall under?
Primary CPC classification A61K47/34. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).